The C19orf47 Knockout HAP1 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population designed for loss-of-function analysis of the uncharacterized C19orf47 gene. This product provides a heterogeneous pool of cells carrying targeted gene disruptions, enabling the study of C19orf47 across a mixed genetic background that more closely mirrors natural biological variation. The polyclonal format is particularly valuable for interrogating gene function without clonal selection biases, allowing researchers to assess the functional consequences of C19orf47 ablation in a near-physiological cellular context.
The host cell line, HAP1, is an adherent near-haploid derivative of the KBM-7 chronic myeloid leukemia cell line. HAP1 cells are extensively employed in functional genomics due to their haploid karyotype, which simplifies knockout generation and phenotype interpretation by reducing genetic redundancy. This near-haploid model system has become a workhorse for CRISPR-based genetic screening, drug target identification, and mechanistic studies in cancer biology and signal transduction. The cells maintain stable growth characteristics and are amenable to a wide range of standard molecular and cellular assays.
C19orf47 encodes a protein of unknown function, with no established links to specific signaling pathways, interaction networks, or disease associations. The mechanistic summary indicates that the gene’s biological role remains completely uncharacterized, making it a focal point for discovery-driven research. This knockout population provides a clean loss-of-function system to investigate potential roles in cellular processes such as proliferation, survival, differentiation, or response to stress. By comparing the polyclonal knockout cells to wild-type controls, researchers can identify C19orf47-dependent phenotypes and begin to map its position within cellular pathways.
In the HAP1 background, the C19orf47 knockout cells offer a particularly powerful platform for functional studies. The near-haploid genome ensures that a single disruption is sufficient to eliminate gene function, avoiding the confounding effects of heterozygosity. This attribute enhances the sensitivity of phenotypic screens and facilitates the detection of subtle defects. Moreover, the polyclonal nature of the product allows for the analysis of population-level responses, which can be more robust and reproducible than monoclonal studies. The combination of a well-characterized host cell line and a gene of unknown function positions this model as an ideal starting point for systematic functional characterization.
Researchers can employ these cells in a variety of experimental workflows, including proliferation and apoptosis assays, transcriptomic profiling via RNA-seq, and protein interaction studies using co-immunoprecipitation. Western blotting and RT-qPCR can be used to confirm knockout at the protein and mRNA levels, respectively. The cells are also suitable for genetic interaction screens to identify synthetic lethal partners or for drug sensitivity profiling to uncover dependencies that could inform therapeutic targeting. For detailed product specifications, technical support, or custom inquiries, please contact Ascent Research.
